❗️🔬Dual targeting of MYC and EZH2 as a promising therapeutic strategy in Aggressive B Cell Lymphomas
Do not miss the last work from our Lymphoma translational group! 👇
https://www.sciencedirect.com/science/article/pii/S1476558625000107
Do not miss the last work from our Lymphoma translational group! 👇
https://www.sciencedirect.com/science/article/pii/S1476558625000107
Comments